SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
不需要昵称
Lv5
1190 积分
2023-09-02 加入
最近求助
最近应助
互助留言
Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37+ lymphoid malignancies
12天前
已关闭
CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study
12天前
已完结
Anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30+ lymphoma: a phase 1 study
12天前
已完结
CAR T-cells and Time-Limited Ibrutinib as Treatment for Relapsed/Refractory Mantle Cell Lymphoma: Phase II TARMAC Study
12天前
已完结
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
12天前
已完结
CAR T-cells and Time-Limited Ibrutinib as Treatment for Relapsed/Refractory Mantle Cell Lymphoma: Phase II TARMAC Study
12天前
已关闭
Analysis of 60 patients with relapsed or refractory T‐cell acute lymphoblastic leukemia and T‐cell lymphoblastic lymphoma treated with CD7‐targeted chimeric antigen receptor‐T cell therapy
16天前
已完结
CD22 CAR T cells demonstrate high response rates and safety in pediatric and adult B-ALL: Phase 1b results
20天前
已完结
SOHO State of the Art Updates and Next Questions | Will CAR-T Replace ASCT in NDMM?
1个月前
已完结
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
1个月前
已完结
Network meta-analysis in psychology and educational sciences: A systematic review of their characteristics
1年前
已采纳
已解决【积分已退回】
5个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论